scholarly journals Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study

2020 ◽  
Author(s):  
Anders Hostrup Larsen ◽  
Henrik Wiggers ◽  
Ole Lindgård Dollerup ◽  
Nichlas Riise Jespersen ◽  
Nils Henrik Hansson ◽  
...  
Keyword(s):  
Heart Failure ◽  
Body Weight ◽  
Insulin Sensitivity ◽  
Chronic Heart Failure ◽  
Controlled Study ◽  
Double Blind ◽  
Increase Insulin Sensitivity ◽  
Double Blind Placebo ◽  
Heart Failure Patients

scholarly journals Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure

1993 ◽  
Vol 22 (1) ◽  
pp. 65-72 ◽  
Author(s):  
Milton Packer ◽  
◽  
Kenneth A. Narahara ◽  
Uri Elkayam ◽  
Jay M. Sullivan ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes

2019 ◽  
Vol 22 (9) ◽  
pp. 1628-1637 ◽  
Author(s):  
Anders Hostrup Larsen ◽  
Niels Jessen ◽  
Helene Nørrelund ◽  
Lars Poulsen Tolbod ◽  
Hendrik Johannes Harms ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Heart Failure Patients ◽  
Insulin Resistant ◽  
Myocardial Efficiency

Long-term clinical effect of nilvadipine in patients with chronic heart failure: A double-blind placebo-controlled study

1994 ◽  
Vol 9 (5) ◽  
pp. 249-253 ◽  
Author(s):  
Masatsugu Hori ◽  
Hideyuki Sato ◽  
Michiko Karita ◽  
Kazuhisa Kodama ◽  
Noritake Hoki ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Clinical Effect ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document